Global Oligonucleotide Array Market Growth 2024-2030

Publication ID:

LPI08240156

Publication Date:

August 1, 2024

Pages:

118

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Semiconductors [2]

Manufacturing (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

The global Oligonucleotide Array market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淥ligonucleotide Array Industry Forecast鈥� looks at past sales and reviews total world Oligonucleotide Array sales in 2023, providing a comprehensive analysis by region and market sector of projected Oligonucleotide Array sales for 2024 through 2030. With Oligonucleotide Array sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide Array industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide Array landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide Array portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Oligonucleotide Array market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide Array and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide Array.
United States market for Oligonucleotide Array is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Oligonucleotide Array is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Oligonucleotide Array is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Oligonucleotide Array players cover Illumnia, Affymetrix, Agilent Technologies, Roche NimbleGen, Sengenics, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide Array market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Long Oligonucleotide Chip
Short Oligonucleotide Chip
Segmentation by Application:
Gene Expression
Genotyping
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Illumnia
Affymetrix
Agilent Technologies
Roche NimbleGen
Sengenics
Arrayit
Applied Microarrays
Biometrix Technology
Savyon Diagnostics
Scienion AG
WaferGen
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oligonucleotide Array market?
What factors are driving Oligonucleotide Array market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oligonucleotide Array market opportunities vary by end market size?
How does Oligonucleotide Array break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oligonucleotide Array Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oligonucleotide Array by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oligonucleotide Array by Country/Region, 2019, 2023 & 2030
2.2 Oligonucleotide Array Segment by Type
2.2.1 Long Oligonucleotide Chip
2.2.2 Short Oligonucleotide Chip
2.3 Oligonucleotide Array Sales by Type
2.3.1 Global Oligonucleotide Array Sales Market Share by Type (2019-2024)
2.3.2 Global Oligonucleotide Array Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oligonucleotide Array Sale Price by Type (2019-2024)
2.4 Oligonucleotide Array Segment by Application
2.4.1 Gene Expression
2.4.2 Genotyping
2.4.3 Others
2.5 Oligonucleotide Array Sales by Application
2.5.1 Global Oligonucleotide Array Sale Market Share by Application (2019-2024)
2.5.2 Global Oligonucleotide Array Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oligonucleotide Array Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Oligonucleotide Array Breakdown Data by Company
3.1.1 Global Oligonucleotide Array Annual Sales by Company (2019-2024)
3.1.2 Global Oligonucleotide Array Sales Market Share by Company (2019-2024)
3.2 Global Oligonucleotide Array Annual Revenue by Company (2019-2024)
3.2.1 Global Oligonucleotide Array Revenue by Company (2019-2024)
3.2.2 Global Oligonucleotide Array Revenue Market Share by Company (2019-2024)
3.3 Global Oligonucleotide Array Sale Price by Company
3.4 Key Manufacturers Oligonucleotide Array Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oligonucleotide Array Product Location Distribution
3.4.2 Players Oligonucleotide Array Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Oligonucleotide Array by Geographic Region
4.1 World Historic Oligonucleotide Array Market Size by Geographic Region (2019-2024)
4.1.1 Global Oligonucleotide Array Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oligonucleotide Array Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oligonucleotide Array Market Size by Country/Region (2019-2024)
4.2.1 Global Oligonucleotide Array Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oligonucleotide Array Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oligonucleotide Array Sales Growth
4.4 APAC Oligonucleotide Array Sales Growth
4.5 Europe Oligonucleotide Array Sales Growth
4.6 Middle East & Africa Oligonucleotide Array Sales Growth
5 Americas
5.1 Americas Oligonucleotide Array Sales by Country
5.1.1 Americas Oligonucleotide Array Sales by Country (2019-2024)
5.1.2 Americas Oligonucleotide Array Revenue by Country (2019-2024)
5.2 Americas Oligonucleotide Array Sales by Type (2019-2024)
5.3 Americas Oligonucleotide Array Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide Array Sales by Region
6.1.1 APAC Oligonucleotide Array Sales by Region (2019-2024)
6.1.2 APAC Oligonucleotide Array Revenue by Region (2019-2024)
6.2 APAC Oligonucleotide Array Sales by Type (2019-2024)
6.3 APAC Oligonucleotide Array Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oligonucleotide Array by Country
7.1.1 Europe Oligonucleotide Array Sales by Country (2019-2024)
7.1.2 Europe Oligonucleotide Array Revenue by Country (2019-2024)
7.2 Europe Oligonucleotide Array Sales by Type (2019-2024)
7.3 Europe Oligonucleotide Array Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oligonucleotide Array by Country
8.1.1 Middle East & Africa Oligonucleotide Array Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oligonucleotide Array Revenue by Country (2019-2024)
8.2 Middle East & Africa Oligonucleotide Array Sales by Type (2019-2024)
8.3 Middle East & Africa Oligonucleotide Array Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oligonucleotide Array
10.3 Manufacturing Process Analysis of Oligonucleotide Array
10.4 Industry Chain Structure of Oligonucleotide Array
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oligonucleotide Array Distributors
11.3 Oligonucleotide Array Customer
12 World Forecast Review for Oligonucleotide Array by Geographic Region
12.1 Global Oligonucleotide Array Market Size Forecast by Region
12.1.1 Global Oligonucleotide Array Forecast by Region (2025-2030)
12.1.2 Global Oligonucleotide Array Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Oligonucleotide Array Forecast by Type (2025-2030)
12.7 Global Oligonucleotide Array Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Illumnia
13.1.1 Illumnia Company Information
13.1.2 Illumnia Oligonucleotide Array Product Portfolios and Specifications
13.1.3 Illumnia Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Illumnia Main Business Overview
13.1.5 Illumnia Latest Developments
13.2 Affymetrix
13.2.1 Affymetrix Company Information
13.2.2 Affymetrix Oligonucleotide Array Product Portfolios and Specifications
13.2.3 Affymetrix Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Affymetrix Main Business Overview
13.2.5 Affymetrix Latest Developments
13.3 Agilent Technologies
13.3.1 Agilent Technologies Company Information
13.3.2 Agilent Technologies Oligonucleotide Array Product Portfolios and Specifications
13.3.3 Agilent Technologies Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Agilent Technologies Main Business Overview
13.3.5 Agilent Technologies Latest Developments
13.4 Roche NimbleGen
13.4.1 Roche NimbleGen Company Information
13.4.2 Roche NimbleGen Oligonucleotide Array Product Portfolios and Specifications
13.4.3 Roche NimbleGen Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Roche NimbleGen Main Business Overview
13.4.5 Roche NimbleGen Latest Developments
13.5 Sengenics
13.5.1 Sengenics Company Information
13.5.2 Sengenics Oligonucleotide Array Product Portfolios and Specifications
13.5.3 Sengenics Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sengenics Main Business Overview
13.5.5 Sengenics Latest Developments
13.6 Arrayit
13.6.1 Arrayit Company Information
13.6.2 Arrayit Oligonucleotide Array Product Portfolios and Specifications
13.6.3 Arrayit Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Arrayit Main Business Overview
13.6.5 Arrayit Latest Developments
13.7 Applied Microarrays
13.7.1 Applied Microarrays Company Information
13.7.2 Applied Microarrays Oligonucleotide Array Product Portfolios and Specifications
13.7.3 Applied Microarrays Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Applied Microarrays Main Business Overview
13.7.5 Applied Microarrays Latest Developments
13.8 Biometrix Technology
13.8.1 Biometrix Technology Company Information
13.8.2 Biometrix Technology Oligonucleotide Array Product Portfolios and Specifications
13.8.3 Biometrix Technology Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Biometrix Technology Main Business Overview
13.8.5 Biometrix Technology Latest Developments
13.9 Savyon Diagnostics
13.9.1 Savyon Diagnostics Company Information
13.9.2 Savyon Diagnostics Oligonucleotide Array Product Portfolios and Specifications
13.9.3 Savyon Diagnostics Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Savyon Diagnostics Main Business Overview
13.9.5 Savyon Diagnostics Latest Developments
13.10 Scienion AG
13.10.1 Scienion AG Company Information
13.10.2 Scienion AG Oligonucleotide Array Product Portfolios and Specifications
13.10.3 Scienion AG Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Scienion AG Main Business Overview
13.10.5 Scienion AG Latest Developments
13.11 WaferGen
13.11.1 WaferGen Company Information
13.11.2 WaferGen Oligonucleotide Array Product Portfolios and Specifications
13.11.3 WaferGen Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 WaferGen Main Business Overview
13.11.5 WaferGen Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂